December 10, 2004 -- Despite a huge drop in the price of crude oil, which lost $1.82 to $40.71 a barrel, stock market indexes ended the week with a small move lower. The Centient Biotech 200™ lost 13.83 points to 3483.81, a decline of .40%. That was more than the NYSE Composite, which was down by .28%, or the Nasdaq, which was almost unchanged, losing just .04%. Among the stocks in the news, we have updates on EntreMed (ENMD), Martek Biosciences (MATK), Applied Biosystems (ABI), Chiron (CHIR), Penwest (PPCO), and Introgen (INGN).
